Rolapitant for the treatment of chemotherapy-induced nausea and vomiting

Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

(2015) T. L. Ng et al.   ONCOLOGIST

Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and Safety

(2015) M. Aapro et al.   ONCOLOGIST

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

(2014) P. J. Hesketh et al.   ANNALS OF ONCOLOGY

A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy

(2014) R. J. Gralla et al.   ANNALS OF ONCOLOGY

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

(2014) M. Aapro et al.   ANNALS OF ONCOLOGY

Palonosetron for the treatment of chemotherapy-induced nausea and vomiting

(2014) Rudolph M Navari   EXPERT OPINION ON PHARMACOTHERAPY

Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review

(2014) Christopher M. Hocking et al.   SUPPORTIVE CARE IN CANCER

Management of Chemotherapy-Induced Nausea and Vomiting

(2013) Rudolph M. Navari   DRUGS

Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced nausea and vomiting

(2013) Rudolph M. Navari   EUROPEAN JOURNAL OF PHARMACOLOGY

Netupitant PET imaging and ADME studies in humans

(2013) Tulla Spinelli et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data

(2012) Antonio Rossi et al.   JOURNAL OF CLINICAL ONCOLOGY

In vitro and in vivo pharmacological characterization of the novel NK1 receptor selective antagonist Netupitant

(2012) Anna Rizzi et al.   PEPTIDES

Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets

(2012) Ruth A. Duffy et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol—EASE

(2011) Steven Grunberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

(2009) Lijun Tan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH